首页> 外文OA文献 >Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

【2h】

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

机译：Dabrafenib与Trametinib组合在治疗BRAF V600阳性晚期或转移性非小细胞肺癌的患者中：临床证据和经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Arjun Khunger; Monica Khunger; Vamsidhar Velcheti;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience [J] . Arjun Khunger, Monica Khunger, Vamsidhar Velcheti Therapeutic advances in respiratory disease. . 2018,第2期

机译：达拉非尼联合曲美替尼治疗BRAF V600阳性晚期或转移性非小细胞肺癌患者的临床证据和经验
2. Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience [J] . Khunger Arjun, Khunger Monica, Velcheti Vamsidhar Therapeutic advances in respiratory disease. . 2018,第1期

机译：Dabrafenib与Trametinib在治疗BRAF v600阳性晚期或转移性非小细胞肺癌的患者中组合：临床证据和经验
3. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial [J] . Planchard David, Besse Benjamin, Groen Harry J. M., The lancet oncology . 2016,第7期

机译：达布拉非尼联合曲美替尼治疗先前治疗过的BRAF（V600E）-突变型转移性非小细胞肺癌患者：一项开放性，多中心，2期试验
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience [O] . Arjun Khunger, Monica Khunger, Vamsidhar Velcheti 2018

机译：达拉非尼联合曲美替尼治疗BRAF V600阳性晚期或转移性非小细胞肺癌患者的临床证据和经验
7. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer:: an open-label, multicentre phase 2 trial [O] . Planchard, David, Besse, Benjamin, Groen, Harry J. M., 2016

机译：达布拉非尼联合曲美替尼在先前治疗过BRAF（V600E）突变型转移性非小细胞肺癌的患者中：一项开放性，多中心，2期试验

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

著录项

引文网络

相似文献

相关主题

期刊订阅